Ronnie Andrews

Insight Genetics has appointed Ronald (Ronnie) Andrews to its board of directors. Andrews also joined the firm's investor base as part of a new $3 million investment round. Andrews is the former president of the genetic science division of Thermo Fisher Scientific, and he was president of medical sciences for Life Technologies before it was acquired by Thermo Fisher. Andrews has also served as CEO of Clarient until its sale to GE Healthcare and is a founder of The Bethesda Group, which works with companies to commercialize their technologies.